cupure logo
jabgamechangingexpertscancerrevealshivstrainenglanddoctorssevere

New breast cancer drug wins FDA approval after slashing progression risk by nearly 40%

New breast cancer drug wins FDA approval after slashing progression risk by nearly 40%
The FDA-approved Inluriyo, an oral estrogen receptor antagonist from Eli Lilly, has shown to achieve significant improvement in progression-free survival for breast cancer.

Comments

Similar News

Health news